Tula® System

Tympanostomy Tube Delivery Product With Drug

FDA Premarket Approval P190016

Pre-market Approval Supplement Details

Approval for the tula® system. This device is intended to create a myringotomy and insert a tympanostomy tube using the tula tube delivery system in pediatric (aged 6 months and older) and adult patients indicated to receive tympanostomy tubes. The tula system is used to deliver a tympanostomy tube under local anesthesia induced using the tula iontophoresis system and tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist. Tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the tula® iontophoresis system in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the tula tube delivery systemdrug indications and usage: tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the tula® iontophoresis system in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the tula tube delivery system.

DeviceTula® System
Classification NameTympanostomy Tube Delivery Product With Drug
Generic NameTympanostomy Tube Delivery Product With Drug
ApplicantTusker Medical, Inc.
Date Received2019-05-31
Decision Date2019-11-25
Notice Date2019-11-27
PMAP190016
SupplementS
Product CodeQJA
Docket Number19M-5605
Advisory CommitteeEar Nose & Throat
Expedited ReviewNo
Combination Product Yes
Applicant Address Tusker Medical, Inc. 155 Jefferson Drive, Suite 200 menlo Park, CA 94025
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P190016Original Filing
S006 2022-09-22 Real-time Process
S005 2022-08-24 30-day Notice
S004
S003 2021-08-09 30-day Notice
S002 2020-10-29 Real-time Process
S001 2020-04-09 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00840128600009 P190016 000
00840128600016 P190016 000
00840128600023 P190016 000
00840128600030 P190016 000
00840128600047 P190016 000
20840128600058 P190016 000
20840128600072 P190016 000
20840128600089 P190016 000
20840128600096 P190016 000
20840128600102 P190016 000
00840128600160 P190016 000
20840128600201 P190016 000
00840128600153 P190016 000
00840128600146 P190016 000
00840128600139 P190016 000
20840128600126 P190016 000
20840128600119 P190016 000
20840128600201 P190016 002
20840128600058 P190016 002
00840128600030 P190016 002
00840128600023 P190016 002
00840128600016 P190016 002
00840128600009 P190016 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.